Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth

Kota Ramana, Ravinder Tammali, Aramati B M Reddy, Aruni Bhatnagar, Satish Srivastava

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Diabetes is associated with increased generation of cytokines and tissue inflammation, but it is unclear how increased cytokine synthesis is causally related to the development of diabetic complications. Here, we report that exposure to high (25 mM) glucose, but not iso-osmotic concentrations of mannitol or 3-methyl glucose, increased TNF-α secretion by rat and human aortic smooth muscle cells in culture. The increase in TNF-α production was prevented by actinomycin D and cycloheximide, indicating transcriptional activation of TNF-α gene. High glucose (HG)-induced TNF-α release was specifically inhibited by protein kinase C (PKC)-δ inhibitor (Rottlerin; EMD Biosciences, San Diego, CA), but not PKC-β2 inhibitor (CGP53353; Tocris Cookson Inc., Ellisville, MO), indicating the possible involvement of PKC-δ in HG signaling. TNF-α secretion was also prevented by pretreating cells with aldose reductase (AR) inhibitors, sorbinil or tolrestat and in cells treated with antisense AR mRNA. Inhibition of AR also prevented the increase in TNF-α mRNA. Addition of anti-TNF-α antibodies or soluble TNF-α receptors 1 and 2 to the medium or RNA interference ablation of TNF-α attenuated nuclear factor-κB activation and prevented HG-stimulated cell growth. These data indicate that AR is required for HG-induced TNF-α synthesis and release. In vivo, the release of TNF-α by HG leading to autocrine stimulation of TNF-α synthesis may be a critical step in the development of the cardiovascular complications of diabetes. Interruption of the autocrine effects of TNF-α may be a useful strategy for treating diabetic vasculopathies.

Original languageEnglish (US)
Pages (from-to)4371-4384
Number of pages14
JournalEndocrinology
Volume148
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Aldehyde Reductase
Vascular Smooth Muscle
Smooth Muscle Myocytes
Tumor Necrosis Factor-alpha
Glucose
Growth
Protein Kinase C
Diabetes Complications
Cytokines
Messenger RNA
Protein C Inhibitor
Tumor Necrosis Factor Receptors
Dactinomycin
Mannitol
Cycloheximide
Protein Kinase Inhibitors
RNA Interference
Transcriptional Activation
Anti-Idiotypic Antibodies
Cell Culture Techniques

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth. / Ramana, Kota; Tammali, Ravinder; Reddy, Aramati B M; Bhatnagar, Aruni; Srivastava, Satish.

In: Endocrinology, Vol. 148, No. 9, 09.2007, p. 4371-4384.

Research output: Contribution to journalArticle

Ramana, Kota ; Tammali, Ravinder ; Reddy, Aramati B M ; Bhatnagar, Aruni ; Srivastava, Satish. / Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth. In: Endocrinology. 2007 ; Vol. 148, No. 9. pp. 4371-4384.
@article{6fba1ad982af4c55899f21745a29a624,
title = "Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth",
abstract = "Diabetes is associated with increased generation of cytokines and tissue inflammation, but it is unclear how increased cytokine synthesis is causally related to the development of diabetic complications. Here, we report that exposure to high (25 mM) glucose, but not iso-osmotic concentrations of mannitol or 3-methyl glucose, increased TNF-α secretion by rat and human aortic smooth muscle cells in culture. The increase in TNF-α production was prevented by actinomycin D and cycloheximide, indicating transcriptional activation of TNF-α gene. High glucose (HG)-induced TNF-α release was specifically inhibited by protein kinase C (PKC)-δ inhibitor (Rottlerin; EMD Biosciences, San Diego, CA), but not PKC-β2 inhibitor (CGP53353; Tocris Cookson Inc., Ellisville, MO), indicating the possible involvement of PKC-δ in HG signaling. TNF-α secretion was also prevented by pretreating cells with aldose reductase (AR) inhibitors, sorbinil or tolrestat and in cells treated with antisense AR mRNA. Inhibition of AR also prevented the increase in TNF-α mRNA. Addition of anti-TNF-α antibodies or soluble TNF-α receptors 1 and 2 to the medium or RNA interference ablation of TNF-α attenuated nuclear factor-κB activation and prevented HG-stimulated cell growth. These data indicate that AR is required for HG-induced TNF-α synthesis and release. In vivo, the release of TNF-α by HG leading to autocrine stimulation of TNF-α synthesis may be a critical step in the development of the cardiovascular complications of diabetes. Interruption of the autocrine effects of TNF-α may be a useful strategy for treating diabetic vasculopathies.",
author = "Kota Ramana and Ravinder Tammali and Reddy, {Aramati B M} and Aruni Bhatnagar and Satish Srivastava",
year = "2007",
month = "9",
doi = "10.1210/en.2007-0512",
language = "English (US)",
volume = "148",
pages = "4371--4384",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth

AU - Ramana, Kota

AU - Tammali, Ravinder

AU - Reddy, Aramati B M

AU - Bhatnagar, Aruni

AU - Srivastava, Satish

PY - 2007/9

Y1 - 2007/9

N2 - Diabetes is associated with increased generation of cytokines and tissue inflammation, but it is unclear how increased cytokine synthesis is causally related to the development of diabetic complications. Here, we report that exposure to high (25 mM) glucose, but not iso-osmotic concentrations of mannitol or 3-methyl glucose, increased TNF-α secretion by rat and human aortic smooth muscle cells in culture. The increase in TNF-α production was prevented by actinomycin D and cycloheximide, indicating transcriptional activation of TNF-α gene. High glucose (HG)-induced TNF-α release was specifically inhibited by protein kinase C (PKC)-δ inhibitor (Rottlerin; EMD Biosciences, San Diego, CA), but not PKC-β2 inhibitor (CGP53353; Tocris Cookson Inc., Ellisville, MO), indicating the possible involvement of PKC-δ in HG signaling. TNF-α secretion was also prevented by pretreating cells with aldose reductase (AR) inhibitors, sorbinil or tolrestat and in cells treated with antisense AR mRNA. Inhibition of AR also prevented the increase in TNF-α mRNA. Addition of anti-TNF-α antibodies or soluble TNF-α receptors 1 and 2 to the medium or RNA interference ablation of TNF-α attenuated nuclear factor-κB activation and prevented HG-stimulated cell growth. These data indicate that AR is required for HG-induced TNF-α synthesis and release. In vivo, the release of TNF-α by HG leading to autocrine stimulation of TNF-α synthesis may be a critical step in the development of the cardiovascular complications of diabetes. Interruption of the autocrine effects of TNF-α may be a useful strategy for treating diabetic vasculopathies.

AB - Diabetes is associated with increased generation of cytokines and tissue inflammation, but it is unclear how increased cytokine synthesis is causally related to the development of diabetic complications. Here, we report that exposure to high (25 mM) glucose, but not iso-osmotic concentrations of mannitol or 3-methyl glucose, increased TNF-α secretion by rat and human aortic smooth muscle cells in culture. The increase in TNF-α production was prevented by actinomycin D and cycloheximide, indicating transcriptional activation of TNF-α gene. High glucose (HG)-induced TNF-α release was specifically inhibited by protein kinase C (PKC)-δ inhibitor (Rottlerin; EMD Biosciences, San Diego, CA), but not PKC-β2 inhibitor (CGP53353; Tocris Cookson Inc., Ellisville, MO), indicating the possible involvement of PKC-δ in HG signaling. TNF-α secretion was also prevented by pretreating cells with aldose reductase (AR) inhibitors, sorbinil or tolrestat and in cells treated with antisense AR mRNA. Inhibition of AR also prevented the increase in TNF-α mRNA. Addition of anti-TNF-α antibodies or soluble TNF-α receptors 1 and 2 to the medium or RNA interference ablation of TNF-α attenuated nuclear factor-κB activation and prevented HG-stimulated cell growth. These data indicate that AR is required for HG-induced TNF-α synthesis and release. In vivo, the release of TNF-α by HG leading to autocrine stimulation of TNF-α synthesis may be a critical step in the development of the cardiovascular complications of diabetes. Interruption of the autocrine effects of TNF-α may be a useful strategy for treating diabetic vasculopathies.

UR - http://www.scopus.com/inward/record.url?scp=34548084566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548084566&partnerID=8YFLogxK

U2 - 10.1210/en.2007-0512

DO - 10.1210/en.2007-0512

M3 - Article

C2 - 17584970

AN - SCOPUS:34548084566

VL - 148

SP - 4371

EP - 4384

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -